Patient | Sex | Age at diagnosis (years) | Parents status | Age at start of ART (years) | Baseline CD4+count (%CD4) | Baseline Viral load (log10copies/ml) | Remarks |
---|---|---|---|---|---|---|---|
1 | F | 11 | Both parents alive; HIV status unknown | 12 | 40 (1%) | Nil | WHO stage 4 at start of ART Clinical follow-up for 2 months No follow-up laboratory data; Died |
2 | M | 8 | Mother dead (HIV-2 positive), Father alive (HIV-negative) | 14 | 280 (27%) | 4.5 | WHO stage 4 at start of ART Clinical follow-up for 38 months Sub-optimal CD4 recovery; >0.5 log10 increase in viral load at 12 weeks; did not achieve virologic suppression throughout follow-up; LTFU |
4 | F | 2 | Both parents HIV-2 positive and alive (both on ART) | 4 | 570 (13%) | 4.6 | WHO stage 3 at start of ART Clinical follow-up for 10 months No CD4 cell gain; ART discontinued at 29 weeks due to poor adherence; No follow-up viral load data; LTFU |
5 | M | 6 | Mother dead, father unknown; both parents HIV status unknown | 6 | 140 (4%) | 3.1 | WHO stage 3 at start of ART Clinical follow-up for 4 months No follow-up laboratory data; Died |
6 | M | 12 | Mother dead, father unknown; both parents HIV status unknown | 12 | 110 (8%) | 4.9 | WHO stage 2 at start of ART Clinical follow-up for 3 months Achieved an increase in CD4 count of 50 cells/mm3 but a 1.0 log10 increase in viral load at 12 weeks; LTFU |